Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Intravenous thrombolytic therapy of ischemic stroke with the drug Revelisa in real clinical practice: results of the IVT-AIS-R study].
Soldatov MA, Klimov LV, Tolmachev AP, Kiseleva TV, Androfagina OV, Beketova EM, Belkina SN, Borisov DN, Karpov DY, Krasyuk MS, Kucheryavaya MV, Minina YD, Novikov DG, Rogozhnikova NV, Tabakman SV, Teliatnik YA, Tretyakov KV, Fadeeva AS, Khan DS, Chirkov AN, Marskaya NA, Shamalov NA. Soldatov MA, et al. Among authors: shamalov na. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(12. Vyp. 2):42-49. doi: 10.17116/jnevro202212212242. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 36582160 Russian.
[Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
Stakhovskaya LV, Shamalov NA, Khasanova DR, Melnikova EV, Agafiina AS, Golikov KV, Bogdanov EI, Yakupova AA, Roshkovskaya LV, Lukinykh LV, Lokshtanova TM, Poverennova IE, Shepankevich LA. Stakhovskaya LV, et al. Among authors: shamalov na. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3. Vyp. 2):55-65. doi: 10.17116/jnevro20171173255-65. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28665371 Clinical Trial. Russian.
[Prevention of venous thrombosis of the lower extremities and pulmonary embolism in neurological patients in the intensive care unit using intermittent pneumatic compression].
Stulin ID, Podgornaia OA, Seleznev FA, Trukhanov SA, Solonskii DS, Shamalov NA, Prikazchikov SV, Tagirov IS, Kudriakov ON, Selezneva MG, Baranov GA, Dobrovolskaia LE, Dobriakov AV, Skliar IA, Sorokina ND. Stulin ID, et al. Among authors: shamalov na. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(10):25-29. doi: 10.17116/jnevro201811810125. Zh Nevrol Psikhiatr Im S S Korsakova. 2018. PMID: 30499492 Russian.
[Genetic characteristics of stroke].
Khasanova LT, Stakhovskaya LV, Koltsova EA, Shamalov NA. Khasanova LT, et al. Among authors: shamalov na. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(12. Vyp. 2):65-72. doi: 10.17116/jnevro201911912265. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 32207720 Review. Russian.
[Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R].
Soldatov MA, Marskaya NA, Barsegova KA, Androfagina OV, Borisov DN, Karpov DY, Kishinevsky MV, Kucheryavaya MV, Tabakman SV, Telyatnik YA, Fadeeva AS, Khan DS, Chirkov AN, Shamalov NA. Soldatov MA, et al. Among authors: shamalov na. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(3. Vyp. 2):33-37. doi: 10.17116/jnevro202112103133. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 33908230 Russian.
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
Gusev EI, Martynov MY, Nikonov AA, Shamalov NA, Semenov MP, Gerasimets EA, Yarovaya EB, Semenov AM, Archakov AI, Markin SS; FRIDA Study Group. Gusev EI, et al. Among authors: shamalov na. Lancet Neurol. 2021 Sep;20(9):721-728. doi: 10.1016/S1474-4422(21)00210-6. Lancet Neurol. 2021. PMID: 34418399 Clinical Trial.
59 results